The UAE capital wants startups, investors and scientists to build the future of preventive healthcare in real time.
Healthcare systems usually change slowly. Abu Dhabi wants to see what happens when one doesn’t.
At the Milken Institute Global Conference this month, Abu Dhabi made a direct appeal to the global health and longevity industry: come experiment here. Speaking before an audience of investors, policymakers and technology leaders, H E Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi (DOH), invited companies to “build, test and scale next-generation health solutions in Abu Dhabi [1].”
Abu Dhabi is positioning itself as something closer to a live operating system for healthcare, a place where AI, biotech and preventive medicine are not sitting in separate silos, but are being wired together inside a functioning national health network.
“Abu Dhabi is a ‘living lab’, and the invitation is open,” Al Mansoori said.
Sounds polished and futuristic, but what Abu Dhabi is attempting is surprisingly tangible. Instead of testing new healthcare tools in isolated pilot programs, the emirate wants companies to trial technologies across real hospitals, ambulances, clinics and public health systems, while collecting data continuously in the background.
Modern healthcare is running into a wall. Populations are aging. Chronic diseases are becoming more common. Costs keep climbing. Most systems still wait for people to get sick before acting. Longevity science, meanwhile, is pushing toward the opposite idea: predicting decline earlier, intervening sooner and extending the number of healthy years people live.
Abu Dhabi appears to believe that transition cannot happen through research papers alone. It needs real-world infrastructure.
Turning health data into foresight
A central part of Abu Dhabi’s strategy is AI, though Al Mansoori deliberately framed it in practical terms. “AI, for us, is not hype, it is a utility,” he said.
In simple terms, the emirate is trying to connect different layers of health information into one system. That includes clinical records, genetic information and data from wearable devices like smartwatches.
Most people already generate health signals every day without thinking about it – heart rate fluctuations, sleep quality, activity levels, stress markers. Normally, those pieces live in disconnected apps or medical files. Abu Dhabi’s ambition is to combine them into a continuous stream of usable insight.
Al Mansoori described it as an “AI-enabled system” integrating genotype, phenotype and wearable data into what functions as a “real-world evidence engine.” Translated into everyday language, the goal is to give healthcare systems something they have historically lacked: memory and foresight.
Instead of relying on occasional snapshots during doctor visits, the system could potentially identify patterns earlier – whether that means detecting rising cardiovascular risk, understanding how patients respond to therapies outside clinical trials or helping physicians intervene before a condition escalates.
For longevity companies, this kind of environment is especially attractive. One of the sector’s biggest bottlenecks is proving whether interventions genuinely improve long-term health in everyday populations, not just in carefully controlled studies. A real-time health infrastructure creates a faster feedback loop between innovation and measurable outcomes.
The rise of the ‘health brain’
At the center of this system is Abu Dhabi’s Unified Medical Operations Command Centre (UMOC), which Al Mansoori described as the “health brain” of the emirate. The facility uses AI Agents to monitor healthcare activity across the system in real time.
“Today, [with AI Agents] we have forty times the manpower of our workforce, detecting incidents in real-time, enabling faster emergency response, care that starts in the ambulance and creating a continuous intelligence loop,” he said.
Imagine a city where emergency services, hospitals and health databases are constantly communicating with one another, where care effectively begins before a patient even arrives at the hospital.
In many countries, healthcare still functions like disconnected islands. Abu Dhabi is trying to build something closer to air traffic control: centralized visibility designed to anticipate problems instead of merely reacting to them.
AI is increasingly moving away from flashy consumer tools and toward quieter infrastructure roles – organizing systems, identifying risk and helping overstretched health workers make faster decisions.
Longevity becomes economic policy
What makes Abu Dhabi’s approach notable is that longevity is not being treated purely as healthcare policy. It is also being framed as economic strategy.
“Abu Dhabi’s long-term plan in health, and in general, is grounded in economic diversification, strategic investment in technology and infrastructure, investing in people, empowered by deep capital reserve,” Al Mansoori said.
Around the world, governments are beginning to recognize that aging populations are not only medical challenges but economic ones. Longer healthspans affect productivity, workforce participation and national healthcare spending.
On the sidelines of the conference, Al Mansoori also met with leaders across longevity, biotechnology, genomics, pediatrics, AI and investment during a dinner hosted under the Future Health – A Global Initiative by Abu Dhabi platform. Discussions focused on predictive care, equitable access and financing models tied to long-term health outcomes.
The conversation is no longer just about helping people live longer, but increasingly about redesigning systems so healthier aging becomes financially sustainable at population scale. That is the real significance of Abu Dhabi’s “living lab.” The emirate is testing whether healthcare itself can evolve from a system built around sickness into one built around prevention, resilience and longevity.
